These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 20112184)

  • 1. Effect of insulin analogs on the decline of hemoglobin in diabetic patients with nephropathy.
    Hasslacher C; Collenberg E; Möcks J
    Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):341-5. PubMed ID: 20112184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin requirement in patients with type 1 diabetes with reduced renal function: human insulin versus analogue insulin].
    Hasslacher C; Vogt C; Raupp D; Dreyhaupt J
    Dtsch Med Wochenschr; 2007 Nov; 132(47):2500-4. PubMed ID: 18027324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin therapy in renal disease.
    Iglesias P; Díez JJ
    Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe hypoglycemia in diabetics with impaired renal function].
    Hasslacher C; Wittmann W
    Dtsch Med Wochenschr; 2003 Feb; 128(6):253-6. PubMed ID: 12571792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Renin-Angiotensin system blockade on hemoglobin levels in type 2 diabetic patients with chronic kidney disease.
    Inoue A; Babazono T; Iwamoto Y
    Am J Hypertens; 2008 Mar; 21(3):317-22. PubMed ID: 18202667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia with impaired erythropoietin response in diabetic patients.
    Thomas MC; Cooper ME; Tsalamandris C; MacIsaac R; Jerums G
    Arch Intern Med; 2005 Feb; 165(4):466-9. PubMed ID: 15738380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
    Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
    Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?
    Fontseré N; Salinas I; Bonal J; Bayés B; Riba J; Torres F; Rios J; Sanmartí A; Romero R
    Nephrol Dial Transplant; 2006 Aug; 21(8):2152-8. PubMed ID: 16702203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of natriuresis in diabetic nephropathy].
    Późniak J
    Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients?
    Spallone V; Maiello MR; Kurukulasuriya N; Barini A; Lovecchio M; Tartaglione R; Mennuni G; Menzinger G
    Diabet Med; 2004 Nov; 21(11):1174-80. PubMed ID: 15498082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased renal glucose metabolism in Type 1 diabetes mellitus.
    Meyer C; Tolias A; Platanisiotis D; Stumvoll M; Vlachos L; Mitrakou A
    Diabet Med; 2005 Apr; 22(4):453-9. PubMed ID: 15787672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic nephropathy: oral anti-diabetic agents or insulin?].
    Gigante E
    G Ital Nefrol; 2006; 23 Suppl 34():S64-7. PubMed ID: 16633998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of metabolic control on hemoglobin level in type 1 diabetic patients with nephropathy].
    Raupp D; Vogt C; Dreyhaupt J; Hasslacher C
    Med Klin (Munich); 2008 Apr; 103(4):185-9. PubMed ID: 18484202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.